**4** ## **Trustees’ Annual Report for the period** **From 01/04/2024 To 31/03/2025** **Charity name:** United Kingdom and Ireland Oesophagogastric Cancer Group ## **Charity registration number:** 1198358 ## **Objectives and Activities** ||SORP reference|| |---|---|---| |Summary of the purposes
of the charity as set out in
its governing document|Para 1.17|For the public benefit, the advancement of
health and saving of lives by (but not limited to)
the following means: a) providing a forum to
share knowledge and for discussion about
medical cases in the field of oncology; b)
providing information and advice to those who
work in the field of oncology about care and
treatment of cancers, including but not limited
to oesophageal and gastric cancer; and c)
carrying out such other charitable activities as
the trustees see fit from time to time which
would improve the standard of care and
treatment of oesophageal and gastric cancer
patients and cancerpatientsgenerally.| |Summary of the main
activities in relation to those
purposes for the public
benefit, in particular, the
activities, projects or
services identified in the
accounts.|Para 1.17 and
1.19|•
Provides
education/advocacy/advice/information
•
Workshops, conferences, seminars
and/or lectures
•
professional training| |Statement confirming
whether the trustees have
had regard to the guidance
issued by the Charity
Commission on public
benefit|Para 1.18|THE UKIOG Charity aims to improve
outcomes for Oesophago gastric cancer
patients by sharing of best practice,
supporting research and facilitating training.
All of these activities are aimed at ultimately
improving the care of cancer patients and
therefore are a benefit to the public.| ## **Additional information (optional)** You may choose to include further statements where relevant about: SORP reference UKIOG does not presently make grants. Para 1.38 Policy on grant making |Policy on social investment
including program related
investment|Para 1.38|UKIOG does not carry out social
investments.| |---|---|---| |Contribution made by
volunteers|Para 1.38|The founders, steering group and
committees are formed of volunteers who
provide their time free of charge.
The only payments made are to faculty /
speakers to support their attendance at the
face to face meetings.| |Other||| ## **Achievements and Performance** ||SORP reference|| |---|---|---| |Summary of the main
achievements of the charity,
identifying the difference the
charity’s work has made to
the circumstances of its
beneficiaries and any wider
benefits to society as a
whole.|Para 1.20|The charity has successfully run 4 virtual
National MDTs where complex cancer
cases are discussed and then learnings
from these cases disseminated. This has
harmonised best practice and highlighted
where centres are offering procedures or
other treatments not on offer in other
centres. This has directly led to the transfer
of patients care to super specialist centres.
We also ran our third face to face annual
event meeting attended by 150 people from
across all the healthcare professions who
look after Oesophageal and gastric cancer
patients. This meeting highlighted the latest
areas of research and shared best practice
in managing these complex patients.
Feedback from this meeting was extremely
positive with over 95% of attendees stating
they would attend again.
We also hosted our second UKIOG
webinar which was attended by people
from across all the healthcare professions
who look after Oesophageal and gastric
cancer patients.| |**Additional information (optional)**
You may choose to include further statements|**Additional information (optional)**
You may choose to include further statements|where relevant about:| |---|---|---| |Achievements against
objectives set|Para 1.41|We achieved our goals for this period.| |||| |---|---|---| |Performance of fundraising
activities against objectives
set|Para 1.41|We fund our activities via sponsorship from
medical companies. This pays for the
events and the remaining money is then
available for other activities.| |Investment performance
against objectives|Para 1.41|N/A| |Other||| ## **Financial Review** |**Financial Review**||| |---|---|---| |Review of the charity’s
financial position at the end
of the period|Para 1.21|We ended the financial period with a sum
of £78,659.80. We have no other assets
and no liabilities.| |Statement explaining the
policy for holding reserves
stating why they are held|Para 1.22|We don’t aim to keep a reserve, but the
sum left at the end of this financial year is
to allow us to prepare for the subsequent
years activities, cover secretarial support
and to invest in a professional website to
allow us to disseminate the training
materials we have created.| |Amount of reserves held|Para 1.22|N/A| |Reasons for holding zero
reserves|Para 1.22|N/A| |Details of fund materially in
deficit|Para 1.24|N/A| |Explanation of any
uncertainties about the
charity continuing as a going
concern|Para 1.23|N/A| |**Additional information (optional)**
You may choose to include further statements|**Additional information (optional)**
You may choose to include further statements|where relevant about:| |---|---|---| |The charity’s principal
sources of funds (including
any fundraising)|Para 1.47|Sponsorship from medical companies.| |Investment policy and
objectives including any
social investment policy
adopted|Para 1.46|N/A| |A description of the principal
risks facing the charity|Para 1.46|None at present. After the first sponsored
events the sponsors have made it clear
they are very happy to continue sponsoring
more events.| |Other||| ## **Structure, Governance and Management** |Description of charity’s
trusts:||N/A| |---|---|---| |Type of governing document
(trust deed, royal charter)|Para 1.25|CIO Constitution.| |How is the charity
constituted?
(e.g unincorporated
association, CIO)|Para 1.25|CIO| |Trustee selection methods
including details of any
constitutional provisions e.g.
election to post or name of
any person or body entitled
to appoint one or more
trustees|Para 1.25|The current three trustees were
responsible for the creation of UKIOG and
its formation as a charity. New trustees will
be appointed as required by a process of
self nomination and then voting by the
steering committee and all the sub
committees that form UKIOG| **Additional information (optional)** You may choose to include further statements where relevant about: |Policies and procedures
adopted for the induction
and training of trustees|Para 1.51|We will use the Charity Excellence
Framework courses to trainee new
trustees.| |---|---|---| |The charity’s organisational
structure and any wider
network with which the
charity works|Para 1.51|The charity is formed of the three trustees,
a steering committee and then a Research
Committee. We have set up three sub
committees in the previous financial year,
each with their own chair.| |Relationship with any
related parties|Para 1.51|**None**| |Other||| ## **Reference and Administrative details** |Charity name|United Kingdom and Ireland Oesophagogastric Cancer Group| |---|---| |Other name the charity uses|| |Registered charitynumber|1198358| |Charity’s principal address|Velindre Cancer Centre,
Velindre Road,
Whitchurch,
Cardiff,
CF14 2TL| ||| ## **Names of the charity trustees who manage the charity** |1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20|**Trustee name**|**Office (if any)**|**Dates acted if not for whole**
**year **|**Name of person (or body) entitled**
**to appoint trustee (ifany)**| |---|---|---|---|---| ||Thomas Crosby|||| ||Christopher Peters|||| ||Elizabeth Smyth|||| |||||| |||||| |||||| |||||| |||||| |||||| |||||| |||||| |||||| |||||| |||||| |||||| |||||| |||||| |||||| |||||| |||||| ## – Corporate trustees names of the directors at the date the report was approved **Director name** N/A Name of trustees holding title to property belonging to the charity |**Trustee name**|**Dates acted if not for whole year**|| |---|---|---| |None||| |||| |||| |||| |||| |||| ## **Funds held as custodian trustees on behalf of others** Description of the assets None held in this capacity Name and objects of the N/A charity on whose behalf the assets are held and how this falls within the custodian charity’s objects Details of arrangements for N/A safe custody and segregation of such assets from the charity’s own assets ## **Additional information (optional)** ## **Names and addresses of advisers (Optional information)** |**Names and addresses of advisers (Optional information)**|**Names and addresses of advisers (Optional information)**|**Names and addresses of advisers (Optional information)**| |---|---|---| |**Type of**
**adviser**
**Name**
**Address**||| |||| |||| |||| |||| |**Name of chief executive or names of senior staff members (Optional information)**||| |||| ## **Exemptions from disclosure** Reason for non-disclosure of key personnel details N/A ## **Other optional information** N/A ## **Declarations** **The trustees declare that they have approved the trustees’ report above.** **Signed on behalf of the charity’s trustees** |**Signature(s)**
**Full name(s)**
**Position (eg Secretary,**
**Chair, etc)**
**Date**||| |---|---|---| ||Prof Thomas Crosby|| ||
Trustee|| ||03/09/2025|| ||03/09/2025|| |Date|Description|Income MoneyIN|Expense MoneyOUT|Overall Balance| |---|---|---|---|---| |03/04/2024|Royal Society of Medicine -
Conferencepayment||14,200.24|15,565.00| |05/04/2024|Payment for website||10.80|15,554.20| |05/04/2024|SponsorshipAstellas|5,000.00||20,554.20| |08/04/2024|Royal Society of Medicine -
Conferencepayment||882.60|19,671.60| |08/04/2024|Donation from relative of apatinet|1,276.63||20,948.23| |12/04/2024|SponsorshipMerck|10,000.00||30,948.23| |30/04/2024|Cardiff Medical Events - conference
organisation||5,543.89|25,404.34| |09/05/2024|Payment for website||40.80|25,363.54| |14/05/2024|Payment for conference||100.00|25,263.54| |22/05/2024|SponsorshipAstra Zeneca|2,500.00||27,763.54| |05/06/2024|Payment for website||10.80|27,752.74| |12/06/2024|Payment for admin to CarlyBiscoe||100.00|27,852.74| |05/07/2024|SponsorshipAstellas|15,000.00||42,852.74| |08/07/2024|Payment for website||10.80|42,841.94| |01/08/2024|Payment to web designer||6,000.00|36,841.94| |07/08/2024|Payment for website||10.80|36,831.14| |27/08/2024|SponsorshipServier|24,000.00||60,831.14| |05/09/2024|Payment for website||10.80|60,820.34| |08/10/2024|Payment for website||10.80|60,809.54| |14/10/2024|Payment for admin to CarlyBiscoe||2,163.52|58,646.02| |17/10/2024|Royal Society of Medicine -
Conferencepayment||6,840.00|51,806.02| |29/10/2024|Payment for admin to CarlyBiscoe||416.06|51,389.96| |05/11/2024|SponsorshipBristol Myers Squibb|5,000.00||56,389.96| |06/11/2024|Payment for website||10.80|56,379.16| |15/11/2024|SponsorshipAstellas|10,000.00||66,379.16| |22/11/2024|SponsorshipMSD|5,000.00||71,379.16| |28/11/2024|Payment for admin to CarlyBiscoe||332.85|71,046.31| |04/12/2024|Payment to web designer||2,400.00|68,646.31| |06/12/2024|Payment for website||10.80|68,635.51| |---|---|---|---|---| |30/12/2024|Payment for admin to CarlyBiscoe||416.06|68,219.45| |07/01/2025|Payment for website||10.80|68,208.65| |31/01/2025|Payment for admin to CarlyBiscoe||416.06|67,792.59| |05/05/2025|Payment for website||10.80|67,781.79| |13/02/2025|Payment for admin to CarlyBiscoe||416.06|67,365.73| |27/02/2025|Payment for web designer||2,340.00|65,025.73| |03/03/2025|Payment to Carly Biscoe for
conference expenses||144.00|64,881.73| |06/03/2025|Payment to Hollie Clements for
conference expenses||187.00|64,694.73| |10/03/2025|Payment for website||14.40|64,680.33| |10/03/2025|Payment to Clarisa Choh for
conference expenses||104.39|64,575.94| |11/03/2025|Lanyardpurchase for conference||291.08|64,284.86| |11/03/2025|Payment to Rebecca Squires for
conference expenses||167.19|64,117.67| |11/03/2025|Payment to Carly Biscoe for
conference expenses||27.96|64,089.71| |14/03/2025|SponsorshipBMS|15,000.00||79,089.71| |17/03/2025|Payment for admin to CarlyBiscoe||416.06|78,673.65| |24/03/2025|Payment to Nick West for conference
expenses||106.30|78,567.35| |24/03/2025|Payment to R Skipworth for
conference expenses||168.47|78,398.88| |25/03/2025|SponsorshipRoche|500.00||78,814.08| |26/03/2025|Payment to Ruth Dacie for conference
expenses||133.69|78,680.39| |27/03/2025|Payment to Carly Biscoe for
conference expenses||20.59|78,659.80| Total Current Assets 0 Total Current Liabilities 0 **Independent examiner's report on the accounts** **Section A Independent Examiner’s Report** **Report to the trustees** Charity Name United Kingdom and Ireland Oesophagogastric Cancer Group **On accounts for the year** 2025 **Charity no** 1198358 **ended (if any) Set out on pages** (remember to include the page numbers of additional sheets) I report to the trustees on my examination of the accounts of the above charity (“the Trust”) for the year ended 31/03/2025 **Responsibilities and** As the charity's trustees, you are responsible for the preparation of the **basis of report** accounts in accordance with the requirements of the Charities Act 2011 (“the Act”). I report in respect of my examination of the Trust’s accounts carried out under section 145 of the 2011 Act and in carrying out my examination, I have followed all the applicable Directions given by the Charity Commission under section 145(5)(b) of the Act. **Independent examiner's statement** I have completed my examination. I confirm that no material matters have come to my attention in connection with the examination (other than that disclosed below *) which gives me cause to believe that in, any material respect: I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached. * _Please delete the words in the brackets if they do not apply._ **Date:** 10.09.2025 **Signed: Name:** Krishna Moorthy **Relevant professional** MD, FRCS **qualification(s) or body (if any): Address:** Hammersmith Hospital, London, W12 0HS **Oct 2018** 1 **IER** **Section B Disclosure** Only complete if the examiner needs to highlight material matters of concern (see CC32, Independent examination of charity accounts: directions and guidance for examiners). **Give here brief details of any items that the examiner wishes to disclose** . Nil **Oct 2018** 2 **IER**